These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6295430)

  • 1. Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
    Skinner GR; Buchan A; Williams D; Marsden J; Hartley C; Wilbanks G; Turyk M; Namkoong ES
    Br J Exp Pathol; 1982 Aug; 63(4):378-87. PubMed ID: 6295430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis.
    Skinner GR; Woodman C; Hartley C; Buchan A; Fuller A; Wiblin C; Wilkins G; Melling J
    Dev Biol Stand; 1982; 52():333-44. PubMed ID: 6299842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.
    Mishkin EM; Fahey JR; Kino Y; Klein RJ; Abramovitz AS; Mento SJ
    Vaccine; 1991 Mar; 9(3):147-53. PubMed ID: 1645898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
    Skinner GR; Woodman CB; Hartley CE; Buchan A; Fuller A; Durham J; Synnott M; Clay JC; Melling J; Wiblin C; Wilkins J
    Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for control of herpes simplex virus disease through immunization.
    Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ
    Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal studies on the efficacy of vaccination against recurrent herpes.
    Scriba M
    Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of a sub-unit vaccine using an animal model of herpes simplex keratitis.
    Harney BA; Easty DL; Skinner GR
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 3)():342-6. PubMed ID: 6324419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus vaccines.
    Meignier B; Roizman B
    Antiviral Res; 1985; Suppl 1():259-65. PubMed ID: 3002260
    [No Abstract]   [Full Text] [Related]  

  • 13. Subviral herpes simplex vaccine.
    Kutinovà L; Slichtová V; Vonka V
    Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance of chicks to Herpes simplex virus].
    Cassai E; Menarini L; Corradini L
    Boll Ist Sieroter Milan; 1972; 51(3):173-6. PubMed ID: 4347184
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-immunological aspects of recurrent herpes simplex during vaccine therapy].
    Semenova TB; Karpovich LG; Barinskiĭ IF; Blokha VV; Kalashnikova TV
    Vestn Dermatol Venerol; 1988; (7):49-53. PubMed ID: 2851233
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody reactivity with Skinner HSV vaccine.
    Muniu EM; Durham J; Shariff D; Hartley CE; Fuller A; Melling J; Wiblin C; Wilkins G; Buchan A; Skinner GR
    Med Microbiol Immunol; 1987; 176(6):315-27. PubMed ID: 2828898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital herpes.
    Oates JK
    Br J Hosp Med; 1983 Jan; 29(1):13-22. PubMed ID: 6297643
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
    Chen MH; Zhou Z; Hartley CE; Cowan M; Skinner GR
    Vaccine; 1986 Dec; 4(4):249-52. PubMed ID: 3026107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral infection of newborn guinea pigs with herpes simplex virus type 1.
    Blaskovic D; Svobodová J; Weidnerová K; Stastný B
    Acta Virol; 1971 Nov; 15(6):522. PubMed ID: 4400435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.